Indo Amines Q1 FY27 Revenue Rises to ₹374.64 Cr, Vadodara Plant Operations Resume

CHEMICALS
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Indo Amines Q1 FY27 Revenue Rises to ₹374.64 Cr, Vadodara Plant Operations Resume

Indo Amines reported a consolidated revenue of ₹374.64 crore for Q1 FY27. Operations at its Vadodara plant have resumed after a closure order was revoked. The company also recommended a final dividend of ₹0.50 per share.

Indo Amines Sees Q1 FY27 Revenue Growth to ₹374.64 Cr, Vadodara Plant Operations Restarted

Consolidated Revenue: ₹374.64 crore
Consolidated Net Profit: ₹30.76 crore

Reader Takeaway: Resilient revenue growth and resolved plant closure are positives; regulatory compliance remains a key focus.

What just happened

Indo Amines announced its financial results for the first quarter ended June 30, 2026 (Q1 FY27), reporting a consolidated revenue of ₹374.64 crore. This marks an increase from ₹317.61 crore in the previous quarter and ₹287.59 crore in the same quarter last year. The company's consolidated net profit for the quarter stood at ₹30.76 crore, up from ₹20.51 crore in the March 2026 quarter. Additionally, the Gujarat Pollution Control Board (GPCB) has revoked the closure order for the company's Vadodara plant, allowing operations to resume.

Why this matters

The revenue growth indicates sustained demand for Indo Amines' chemical products. The resumption of operations at the Vadodara plant is crucial as it removes a significant operational risk that could have impacted production and profitability. The recommended final dividend of ₹0.50 per share offers a direct return to shareholders.

The backstory

Indo Amines operates in the chemical manufacturing sector. The Vadodara plant faced a closure order from the GPCB on July 21, 2026, due to environmental concerns. The company responded to the GPCB, leading to the revocation of this order on August 11, 2026.

What changes now

With the regulatory hurdle cleared, the Vadodara plant can now operate at full capacity, contributing to revenue and profit. This operational continuity is vital for meeting market demand and achieving future growth targets. The company also granted 560,000 employee stock options, recognizing approximately ₹0.21 crore as compensation expense.

Risks to watch

While the closure order has been revoked, investors should closely monitor the company's adherence to environmental regulations at the Vadodara site to prevent any future disruptions. Any repeat non-compliance could lead to further operational halts and financial impact.

Peer comparison

(Peer comparison data not available in the filing. General context: The chemical industry in India is competitive, with companies often facing regulatory scrutiny related to environmental compliance. Growth is driven by domestic demand and export opportunities.)

Context metrics (time-bound)

  • Q1 FY27 Revenue: ₹374.64 crore (vs. ₹317.61 cr in Q4 FY26 and ₹287.59 cr in Q1 FY26)
  • Q1 FY27 Net Profit: ₹30.76 crore (vs. ₹20.51 cr in Q4 FY26 and ₹28.84 cr in Q1 FY26)
  • Vadodara Plant Closure Order Revoked: August 11, 2026
  • Recommended Final Dividend: ₹0.50 per equity share (Face value ₹5)
  • Employee Stock Options Granted: 560,000

What to track next

Investors should track the company's performance in the upcoming quarters, focusing on revenue sustainability, profitability margins, and any further updates on regulatory compliance at all its manufacturing facilities. The successful integration and operation of the Vadodara plant will be a key indicator.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.